Analysis by Ulcer Type (Neuropathic Ulcer, Ischemic Ulcer, and Neuro-Ischemic Ulcer); by Product (Wound-Care Dressings, Wound-Care Devices, Active Therapies, And Others); and by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Buy Now
The global diabetic foot ulcer treatment market is estimated to garner a revenue of around USD 13 Billion by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of nearly USD 6 Billion in the year 2022. The growth of the market can be attributed to the increasing number of people suffering from diabetes worldwide. The World Health Organization reports that in 2019, diabetes directly caused 1.5 million deaths, with 48% of deaths caused by diabetes occurring before 70 years of age. According to the American Diabetes Association, approximately 11.3% of the American population, or 37.3 million people, had diabetes in 2019. There are 37.3 million adults with diabetes, 28.7 million of whom are diagnosed, and 8.5 million of whom are undiagnosed.
An ulcer on the bottom of the foot is one of the most common diabetic foot complications. By reducing the pressure, promoting healing, and minimizing the chances of amputation, diabetic foot ulcer treatments are particularly useful for treating diabetic foot ulcers. With the aid of advanced medical technology, the diabetic foot ulcer treatment market strives to provide the best possible services in order to facilitate faster and better wound healing for diabetics. Globally, diabetes is becoming one of the most prevalent diseases. Moreover, the rapid adoption of novel wound care devices, the increase in chronic illnesses, such as diabetes and cancer, have contributed to an increase in diabetic foot ulcers among diabetics, and increased disposable incomes are projected to drive market growth over the forecast period. In July 2022, the Bureau of Economic Analysis reported an increase of USD 37.6 billion in disposable personal income, while personal income was up 0.2%.
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~6% |
|
Base Year Market Size (2022) |
~ USD 2 Billion |
|
Forecast Year Market Size (2033) |
~ USD 13 Billion |
|
Regional Scope |
|
Growth Drivers
An Increase In Sedentary Lifestyles- According to the Centers For Disease Control And Prevention, approximately 60% of U.S. adults fail to engage in an adequate amount of physical activity. Nearly 25 percent of American adults are completely sedentary. An increasing number of diabetics are being diagnosed as a result of physical inactivity. In times of rapid modernization, the food habits of the people have been adversely affected, which in turn has been combined with a faulty and inactive lifestyle. Ultimately, this results in the onset of diabetes and leads to the formation of diabetic foot ulcers as a result. This factor is anticipated to drive global diabetic foot ulcer treatment market growth over the forecast period.
Rise in The Geriatric Population Around The World- The group of elderly are particularly affected by diabetes, as their immunity lowers due to old age, they become the prime age group to be burdened with diabetic foot ulcers. According to a recent report published by the World Bank, at the end of 2021, there were a total of 747,238,580 people over 60 years of age living around the world, and the number of elderly people is anticipated to rise in the future.
Rapidly Growing Number of People Developing Diabetic Foot Ulcers (DFU)- It is estimated that between 9 and 26 million people worldwide suffer from diabetic foot ulcers every year. A diabetic foot ulcer is likely to develop during the lifetime of 16 to 24% of patients with diabetes complications.
Increasing Prevalence of Obesity Worldwide- Obesity is one the primary risk factors of diabetic ulcers, obesity defects the tissues that causes insulin resistance and glucose uptake. In the period 2000-2020, obesity prevalence increased by 30.5% to 41.9% in the United States. Ages 20-39 showed an obesity prevalence of 39.8%, 40-59 age groups, 44.3%, and 60+ age groups showed a prevalence of 41.5%.
Surge In Number Of People Suffering From Type 2 Diabetes - It is expected that the worldwide prevalence of type 2 diabetes will increase to 70,000 per 100,000 individuals by 2030, reflecting an increase in prevalence across all regions of the world.
Challenges
The global diabetic foot ulcer treatment market is segmented and analyzed for demand and supply by ulcer type into a neuropathic ulcer, ischemic ulcer, and neuro-ischemic ulcer. Among these segments, the neuropathic ulcer segment is anticipated to capture the largest market size in the global diabetic foot ulcer treatment market owing to an increase in peripheral neuropathy cases among diabetics. It was observed that approximately 48% of diabetic patients experience peripheral neuropathy at some point in their lives, with prevalence ranging from 7% to 50% based on factors such as diabetes type and glycemic control. Furthermore, the number of risks associated with neuropathic ulcers, such as infection, amputation, and death, and increasing treatment options for ulcer diagnosis is projected to augment segment growth over the forecast period.
The global diabetic foot ulcer treatment market is also segmented and analyzed for demand and supply by end-user into hospitals, clinics, ambulatory surgical centers, and homecare. Amongst these four segments, the hospital segment is expected to garner a significant share. The patient suffering with diabetic ulcers should be taken to hospitals, as ulcers can lead to severe infection and it can increase the risk of amputation. Therefore, to avoid the stage of amputation, the patient should be given immediate care of the hospital for dealing with complicated ulcers. The properly trained staff of the hospital can provide intensive care and the patient can be treated with multiple services present in the hospital.
Our in-depth analysis of the global diabetic foot ulcer treatment market includes the following segments:
|
By Ulcer Type |
|
|
By Product |
|
|
By End User |
|
The North American diabetic foot ulcer treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be attributed majorly to the ulcer type into a neuropathic ulcer, ischemic ulcer, and neuro-ischemic ulcer. Among these segments, the neuropathic ulcer segment is anticipated to capture the largest market size in the global diabetic foot ulcer treatment market owing to an increase in peripheral neuropathy cases among diabetics. It was observed that approximately 48% of diabetic patients experience peripheral neuropathy at some point in their lives, with prevalence ranging from 7% to 50% based on factors such as diabetes type and glycemic control. Furthermore, the number of risks associated with neuropathic ulcers, such as infection, amputation, and death, and increasing treatment options for ulcer diagnosis is projected to augment segment growth over the forecast period.
The Asia Pacific diabetic foot ulcer treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The market growth in the region is expected on the account of a rise in the number of patients suffering from diabetes. According to the World Health Organization around 77 million Indians over the age of 18 have type 2 diabetes, and over 25 million are prediabetics More than 50% of people do not know they have diabetes, which can cause serious health problems if not diagnosed timely and not provided with adequate treatment. Moreover, this number of further expected to reach around 135 million by 2045.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Ans: An increase in sedentary lifestyles, surge in number of people suffering from type 2 diabetes along with increasing obesity among people are the major factors driving the market growth.
Ans: The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023 – 2033.
Ans: High cost associated with advanced diabetic foot ulcer treatment and patient management rules and regulations are the challenges affecting the market growth.
Ans: The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.
Ans: The major players in the market are UPM, Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Hill-Rom Holdings, Inc., ConvaTec Inc.
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by ulcer type, product, end user and, by region.
Ans: The neuropathic ulcer segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
